Results 181 to 190 of about 265,921 (362)

Low‐field MRI: Clinical promise and challenges

Journal of Magnetic Resonance Imaging, Volume 57, Issue 1, Page 25-44, January 2023., 2023
Modern MRI scanners have trended toward higher field strengths to maximize signal and resolution while minimizing scan time. However, high‐field devices remain expensive to install and operate, making them scarce outside of high‐income countries and major population centers.
Thomas Campbell Arnold, Colbey W. Freeman, Brian Litt, Joel M. Stein   +3 more
wiley   +1 more source

Serial surveillance cultures of skin and catheter hub specimens from critically ill patients with central venous catheters: molecular epidemiology of infection and implications for clinical management and research [PDF]

, 1997
Isabel Atela, Pere Coll, Jordi Rello, Elisabet Quintana, Javier Barrio, F March, F Sánchez, P Barraquer, J. Ballús, A. Cotura, Guillem Prats   +10 more
openalex   +1 more source

Left Cardiac Border Central Venous Catheter Malposition

, 1987
T. L. Lee
openalex   +1 more source

Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria [PDF]

, 1996
Steven Schmitt, C C Knapp, Geraldine S. Hall, David L. Longworth, James T. McMahon, John A. Washington   +5 more
openalex   +1 more source

Severe Anaphylactic Reaction Due to a Chlorhexidine-impregnated Central Venous Catheter [PDF]

, 1998
Etsuji Terazawa, H Shimonaka, Kiyoshi Nagase, Tatsuhiko Masue, Shuji Dohi   +4 more
openalex   +1 more source

Suturing central venous catheters [PDF]

British Journal of Anaesthesia, 2017
openaire   +3 more sources

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Alzheimer's disease (AD), characterized by β‐amyloid (Aβ) plaques and neurofibrillary tangles, is the leading cause of dementia globally. Donanemab is a humanized immunoglobulin G1 in development as a treatment to slow AD progression. This study aimed to evaluate the safety, tolerability, pharmacokinetics (PKs), and immunogenicity of donanemab
Junyu Xu, Nan Zhao, Yihui Wang, Ivelina Gueorguieva, Chenxi Qian, Yimin Cui   +5 more
wiley   +1 more source

CEUS‐assessed supraspinatus muscle perfusion improves after tendon repair and predicts anatomical and functional outcome: A 1‐year prospective pilot study

Journal of Orthopaedic Research, Volume 41, Issue 2, Page 426-435, February 2023., 2023
Abstract Rotator cuff tear including SSP (Supraspinatus) tendon tears are a very common and often painful condition with several therapeutic options such as tendon repair. Reflected by the high retear rates, the preoperative selection of patients suitable for surgery or conservative treatment, which often yields comparable results, remains difficult ...
Paul Mick, Pierre Kunz, Christian Fischer, Sascha Gross, Julian Doll   +4 more
wiley   +1 more source

Effects of glepaglutide, a long‐acting glucagon‐like peptide‐2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial

Journal of Parenteral and Enteral Nutrition, Volume 47, Issue 1, Page 140-150, January 2023., 2023
Abstract Background The proadaptive effects of glucagon‐like peptide‐2 (GLP‐2) include stimulation of intestinal mucosal growth as well as intestinal blood flow and angiogenesis. We have recently reported that daily subcutaneous injections of glepaglutide, a long‐acting GLP‐2 analog, improved intestinal absorptive function in patients with short bowel ...
Rahim M. Naimi, Mark K. Hvistendahl, Steen S. Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj A. Nerup, Rikard Ambrus, Michael P. Achiam, Lars B. Svendsen, Palle B. Jeppesen   +9 more
wiley   +1 more source

Book Review: A Manual of Central Venous Catheterization and Parenteral Nutrition

, 1983
D. P. Cuthbertson
openalex   +1 more source